SummaryRMgm-5209
|
Successful modification | The parasite was generated by the genetic modification |
The mutant contains the following genetic modification(s) | Gene disruption |
Reference (PubMed-PMID number) |
Reference 1 (PMID number) : 35594144 |
MR4 number | |
top of page | |
Parent parasite used to introduce the genetic modification | |
Rodent Malaria Parasite | P. berghei |
Parent strain/line | P. berghei ANKA |
Name parent line/clone | Not applicable |
Other information parent line | |
top of page | |
The mutant parasite was generated by | |
Name PI/Researcher | Srivastava PN, Mishra S |
Name Group/Department | Division of Molecular Microbiology and Immunology |
Name Institute | CSIR-Central Drug Research Institute |
City | Lucknow |
Country | India |
top of page | |
Name of the mutant parasite | |
RMgm number | RMgm-5209 |
Principal name | CmanT- |
Alternative name | |
Standardized name | |
Is the mutant parasite cloned after genetic modification | Yes |
top of page | |
Phenotype | |
Asexual blood stage | Not different from wild type |
Gametocyte/Gamete | Not different from wild type |
Fertilization and ookinete | Normal, wild-type gametocyte and ookinete production. However, ookinetes showed strongly reduced motility and motion velocity. No oocysts are formed |
Oocyst | No oocyst formation |
Sporozoite | No oocyst and sporozoite formation |
Liver stage | Not tested |
Additional remarks phenotype | Mutant/mutation Additional information See also the paper 'Tryptophan C-mannosylation is critical for Plasmodium falciparum transmission for mutants lacking DPY19' (PMID: 35906227). From the Abstract: 'DPY19-deficiency abolishes C-glycosylation, destabilizes members of the TRAP adhesin family and inhibits transmission to mosquitoes'. Mutants show defects in gametocyte egress, exflagellation, ookinete infectivity ond oocyst production (and mosquito infectivity). Evidence is presented that C-glycosylation is dispensable in P. falciparum salivary gland sporozoites (because O-fucosylation of essential TSR proteins like TRAP is sufficient to compensate for the absence of tryptophan C-mannosylation). Other mutants |
top of page | |||||||||||||||||||||||||
Details of the target gene | |||||||||||||||||||||||||
Gene Model of Rodent Parasite | PBANKA_1224500 | ||||||||||||||||||||||||
Gene Model P. falciparum ortholog | PF3D7_0806200 | ||||||||||||||||||||||||
Gene product | Dpy-19-like C-mannosyltransferase | ||||||||||||||||||||||||
Gene product: Alternative name | CmanT, DPY19 | ||||||||||||||||||||||||
top of page | |||||||||||||||||||||||||
Details of the genetic modification | |||||||||||||||||||||||||
Inducable system used | No | ||||||||||||||||||||||||
Additional remarks inducable system | |||||||||||||||||||||||||
Type of plasmid/construct used | (Linear) plasmid double cross-over | ||||||||||||||||||||||||
PlasmoGEM (Sanger) construct/vector used | No | ||||||||||||||||||||||||
Modified PlasmoGEM construct/vector used | No | ||||||||||||||||||||||||
Plasmid/construct map | |||||||||||||||||||||||||
Plasmid/construct sequence | |||||||||||||||||||||||||
Restriction sites to linearize plasmid | |||||||||||||||||||||||||
Partial or complete disruption of the gene | Complete | ||||||||||||||||||||||||
Additional remarks partial/complete disruption | |||||||||||||||||||||||||
Selectable marker used to select the mutant parasite | hdhfr/yfcu | ||||||||||||||||||||||||
Promoter of the selectable marker | eef1a | ||||||||||||||||||||||||
Selection (positive) procedure | pyrimethamine | ||||||||||||||||||||||||
Selection (negative) procedure | No | ||||||||||||||||||||||||
Additional remarks genetic modification | To replace PbCmanT with a targeting construct, two homology regions (F1, 5′ UTR and F2, 3′ UTR) were amplified using primers 1292/1293 and 1294/1295 and cloned at SalI and NotI/AscI, respectively, in the pBC-GFP-hDHFR:yFCU vector. The resulting construct was linearized with XhoI/AscI. | ||||||||||||||||||||||||
Additional remarks selection procedure | |||||||||||||||||||||||||
Primer information: Primers used for amplification of the target sequences
Primer information: Primers used for amplification of the target sequences
| |||||||||||||||||||||||||
top of page |